|
Age (year)
|
62.2 ± 14.9
|
67.2 ± 8.5
|
0.125
|
|
Gender (male, %)
|
10, 71.4%
|
31, 73.8%
|
0.862
|
|
Weight (kg)
|
64.4 ± 10.4
|
62.4 ± 8.6
|
0.477
|
|
NYHA class (n, %)
| | |
0.329
|
|
I
|
0
|
0
| |
|
II
|
0
|
1, 2.3%
| |
|
III
|
6, 42.8%
|
23, 54.8%
| |
|
IV
|
8, 57.2%
|
18, 42.9%
| |
|
EuroSCORE II
|
30.5 ± 17.5
|
20.9 ± 7.6
|
0.006
|
|
Previous Medical History (n,%)
| | | |
|
Acute Myocardial infarction
|
5, 35.7%
|
9, 21.4%
|
0.285
|
|
Diabetes Mellitus
|
7, 50.0%
|
11, 26.2%
|
0.099
|
|
Chronic Renal Failure
|
0
|
0
|
—
|
|
Hypertension
|
11, 78.6%
|
24, 26.2%
|
0.151
|
|
Liver Disease
|
0
|
0
|
—
|
|
Smoking
|
5, 35.7%
|
11, 26.2%
|
0.495
|
|
Type of cardiac operation (n,%)
| | |
0.890
|
|
CABG
|
1, 7.1%
|
4, 9.5%
| |
|
Valvular surgery
|
5, 35.7%
|
14, 33.3%
| |
|
CABG + Valvular surgery
|
4, 28.6%
|
13, 31.0%
| |
|
Aortic surgery
|
4, 28.6%
|
11, 26.2%
| |
|
CPB time
|
251.1 ± 79.7
|
218.1 ± 80.4
|
0.20
|
|
ACC time
|
187.8 ± 65.1
|
157.8 ± 58.2
|
0.12
|
|
Pre-operation liver function
| | | |
|
ALT
|
29.0 (13.4–58.7)
|
25.0.3 (17–51.3)
|
0.813
|
|
AST
|
34.1 (20.2–109.4)
|
30.5 (17.9–37.6)
|
0.348
|
|
GGT
|
102.8 ± 70.9
|
74.1 ± 38.2
|
0.225
|
|
TBil
|
23.3 ± 15.1
|
18.3 ± 9.9
|
0.157
|
|
DBil
|
10.3 ± 7.3
|
9.6 ± 6.4
|
0.715
|
|
LDH
|
230.9 ± 116.5
|
183.4 ± 83.4
|
0.176
|
|
Serum albumin
|
38.7 ± 4.8
|
38.8 ± 3.5
|
0.906
|
|
Pre-operation Serum Creatinine
|
115.9 ± 77.5
|
95.4 ± 53.8
|
0.276
|
